IMNM: Immunome Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | T. Rowe Price Investment Management, Inc. | 17.40% | SEC | |
| 2026-08-14 | Fell below 5% | Sirenia Capital Management LP | 4.30% | SEC |
Institutional ownership (Q2 2026)
202 institutions reported holding $2.05B of Immunome Inc. on Form 13F (202 the quarter before). 29 opened a new position and 28 sold out. Shares held by institutions: +1%.
| Largest holders | Shares | Value |
|---|---|---|
| FMR LLC | 16,987,553 | $359.97M |
| BlackRock, Inc. | 8,805,492 | $186.59M |
| STATE STREET CORP | 5,494,625 | $116.43M |
| WELLINGTON MANAGEMENT GROUP LLP | 5,210,216 | $110.40M |
| Redmile Group, LLC | 4,911,590 | $104.08M |
| PRIMECAP MANAGEMENT CO/CA/ | 4,581,431 | $97.08M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,551,289 | $96.44M |
| Driehaus Capital Management LLC | 4,346,139 | $92.09M |
| ENAVATE SCIENCES GP, LLC | 3,613,799 | $76.58M |
| GEODE CAPITAL MANAGEMENT, LLC | 2,754,889 | $58.39M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.